Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Alzheimer's treatment subject to postcode lottery

  • Comment

New data suggests the treatment patients receive for Alzheimer’s disease is heavily dependent on where they live.

The research, published by IMS Health, shows there is a postcode lottery for key cholinesterase inhibitors including donepezil, rivastigmine and galantamine.

The drugs are only used to treat people on the NHS with moderately severe Alzheimer, but this decision by NICE in 2007 has caused outrage among campaigners.

Data shows that the drugs were prescribed the least often in the South West and West Midlands, but patients in the North West and South Central regions had much better access to the drugs.

Although it shows that use of the drugs has increased in the UK by 33% over the last three years, regional variations across England could be as much as 70%.

The figures also show that the uptake of the drugs in the UK is well behind other countries.

But Professor Clive Ballard, director of research at the Alzheimer’s Society, said anti-psychotic prescribing remained ‘inappropriately high’ and should only be used to treat severe symptoms or in exceptional circumstances and for short periods.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.